Cancer Research UK is one of the world’s largest non-profit investors in cancer research. Cancer Research UK has built a network of 4,000 exceptional scientists and now funds over £400m of world-class academic research each year that has the potential to change the way we prevent, diagnose, and treat cancer. Cancer Research Horizons, Cancer Research UK’s innovation arm, offers the full spectrum of translational expertise, from drug discovery and clinical capabilities, translational funding and entrepreneurial training to licensing, industry collaboration and start- up creation expertise. It has played a role in the creation of 90+ start-ups, with its portfolio companies raising over £3bn in total capital.

Its dedicated Ventures team focuses on early-stage, high-risk companies, including one of the most challenging stages or start-up creation: attracting early-stage risk capital. The Ventures team manages the Cancer Research Horizons Seed Fund, launched in June 2022, to accelerate more breakthroughs to patient benefit.